{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:59:22Z","timestamp":1787021962269,"version":"build-2736575974"},"reference-count":48,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2015,9,23]],"date-time":"2015-09-23T00:00:00Z","timestamp":1442966400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0139062","type":"journal-article","created":{"date-parts":[[2015,9,23]],"date-time":"2015-09-23T14:02:34Z","timestamp":1443016954000},"page":"e0139062","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":19,"title":["Cost of Preventing, Managing, and Treating Human Papillomavirus (HPV)-Related Diseases in Sweden before the Introduction of Quadrivalent HPV Vaccination"],"prefix":"10.1371","volume":"10","author":[{"given":"Ellinor","family":"\u00d6stensson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Fr\u00f6berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Leval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Cathrin","family":"Hellstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"B\u00e4cklund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas","family":"Zethraeus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,9,23]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1093\/annonc\/mdm377","article-title":"Burden of cervical cancer in the 27 member states of the European Union: estimates for 2004","volume":"18","author":"M Arbyn","year":"2007","journal-title":"Ann Oncol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3111\/13696990801961611","article-title":"Economic burden associated with the management of cervical cancer, cervical dysplasia and genital warts in Belgium","volume":"11","author":"L Annemans","year":"2008","journal-title":"J Med Econ"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1086\/522863","article-title":"The burden of genital warts: a study of nearly 70,000 women from the general female population in the 4 Nordic countries","volume":"196","author":"SK Kjaer","year":"2007","journal-title":"J Infect Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"JM Walboomers","year":"1999","journal-title":"J Pathol"},{"key":"ref5","article-title":"HIV and other sexually transmitted infections in the United Kingdom","year":"2007"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/ijc.20244","article-title":"Against which human papillomavirus types shall we vaccinate and screen? The international perspective","volume":"111","author":"N Munoz","year":"2004","journal-title":"Int J Cancer"},{"issue":"Suppl 3","key":"ref7","first-page":"S3\/1","article-title":"Chapter 1: HPV in the etiology of human cancer","volume":"24","author":"N Munoz","year":"2006","journal-title":"Vaccine"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1136\/sti.76.3.162","article-title":"European course on HPV associated pathology: guidelines for primary care physicians for the diagnosis and management of anogenital warts","volume":"76","author":"G von Krogh","year":"2000","journal-title":"Sex Transm Infect"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/1523-1747.ep12276576","article-title":"Papillomavirus infection of the anogenital region: correlation between histology, clinical picture, and virus type. Proposal of a new nomenclature","volume":"85","author":"G Gross","year":"1985","journal-title":"J Invest Dermatol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1128\/JCM.37.10.3316-3322.1999","article-title":"Detection of multiple human papillomavirus types in Condylomata acuminata lesions from otherwise healthy and immunosuppressed patients","volume":"37","author":"DR Brown","year":"1999","journal-title":"J Clin Microbiol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/oxfordjournals.jncimonographs.a003479","article-title":"Chapter 1: Human papillomavirus and cervical cancer\u2014burden and assessment of causality","author":"FX Bosch","year":"2003","journal-title":"J Natl Cancer Inst Monogr"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/sj.bjc.6690666","article-title":"Trends in cancer of the cervix uteri in Sweden following cytological screening","volume":"81","author":"R Bergstrom","year":"1999","journal-title":"Br J Cancer"},{"key":"ref13","unstructured":"Board of Health and Welfare. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.socialstyrelsen.se\/statistik\" xlink:type=\"simple\">http:\/\/www.socialstyrelsen.se\/statistik<\/ext-link>. Swedish. Accessed February 28, 2014."},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1016\/j.ejca.2009.07.017","article-title":"Description of the national situation of cervical cancer screening in the member states of the European Union","volume":"45","author":"A Anttila","year":"2009","journal-title":"Eur J Cancer"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1093\/jnci\/djn099","article-title":"Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden","volume":"100","author":"B Andrae","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S1470-2045(13)70570-9","article-title":"Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis","volume":"15","author":"M Arbyn","year":"2014","journal-title":"Lancet Oncol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/bjc.2011.277","article-title":"Short-time repeat high-risk HPV testing by self-sampling for screening of cervical cancer","volume":"105","author":"U Gyllensten","year":"2011","journal-title":"Br J Cancer"},{"key":"ref18","article-title":"Swedish National Quality Register for Cervical Cancer Prevention\u2014Report","author":"P Sparen","year":"2010"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1111\/j.1468-3083.2012.04493.x","article-title":"2012 European guideline for the management of anogenital warts","volume":"27","author":"CJ Lacey","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"e0128270","DOI":"10.1371\/journal.pone.0128270","article-title":"Barriers to and facilitators of compliance with clinic-based cervical cancer screening: population-based cohort study of women aged 23\u201360 years","volume":"10","author":"E Ostenson","year":"2015","journal-title":"PLoS One"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/aogs.12143","article-title":"Projected cost-effectiveness of repeat high-risk human papillomavirus testing using self-collected vaginal samples in the Swedish cervical cancer screening program","volume":"92","author":"E Ostensson","year":"2013","journal-title":"Acta Obstet Gynecol Scand"},{"key":"ref22","unstructured":"Engholm G, Ferlay J, Christensen N, Kejs AMT, Johannesen TB, Khan S, et al. NORDCAN: Cancer Incidence, Mortality, Prevalence and Survival in the Nordic Countries, Version 7.1 (09.07.2015). Association of the Nordic Cancer Registries. Danish Cancer Society. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.ancr.nu\" xlink:type=\"simple\">http:\/\/www.ancr.nu<\/ext-link>. Accessed February 1, 2014."},{"key":"ref23","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ygyno.2013.06.012","article-title":"Palliative and hospice care in gynecologic cancer: A review","volume":"131","author":"M Lopez-Acevedo","year":"2013","journal-title":"Gynecol Oncol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ygyno.2012.06.025","article-title":"The utilization of palliative care in gynecologic oncology patients near the end of life","volume":"127","author":"J Fauci","year":"2012","journal-title":"Gynecol Oncol"},{"key":"ref25","article-title":"Advanced home care in Sweden\u2014Extent and costs","author":"I Hemsjukv\u00e5rd","year":"1997"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/infdis\/jis405","article-title":"Incidence of genital warts in Sweden before and after quadrivalent human papillomavirus vaccine availability","volume":"206","author":"A Leval","year":"2012","journal-title":"J Infect Dis"},{"key":"ref27","unstructured":"Health Protection Agency. Supplementary table of sexually transmitted infections in the United Kingdom 2003\u20132012,STI data for UK. 2009. Avaliable: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/webarchive.nationalarchives.gov.uk\/20140714084352\/http:\/\/www.hpa.org.uk\/web\/HPAweb&HPAwebStandard\/HPAweb_C\/1203348026613\" xlink:type=\"simple\">http:\/\/webarchive.nationalarchives.gov.uk\/20140714084352\/http:\/\/www.hpa.org.uk\/web\/HPAweb&amp;HPAwebStandard\/HPAweb_C\/1203348026613<\/ext-link>. Accessed June 30, 2015."},{"key":"ref28","unstructured":"ECDC surveillance report. Annual epidemiological report. Sexually transmitted infections, including HIV and blood-borne viruses 2014. Available at: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/ecdc.europa.eu\/en\/publications\/Publications\/sexually-transmited-infections-HIV-AIDS-blood-borne-annual-epi-report-2014.pdf\" xlink:type=\"simple\">http:\/\/ecdc.europa.eu\/en\/publications\/Publications\/sexually-transmited-infections-HIV-AIDS-blood-borne-annual-epi-report-2014.pdf<\/ext-link>"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1136\/sti.2010.048421","article-title":"Genital warts and cost of care in England","volume":"87","author":"S Desai","year":"2011","journal-title":"Sex Transm Infect"},{"issue":"Suppl 3","key":"ref30","first-page":"S3\/35","article-title":"Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6\/11 disease","volume":"24","author":"CJ Lacey","year":"2006","journal-title":"Vaccine"},{"key":"ref31","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198529446.001.0001","article-title":"Methods for the economic evaluation of health care programmes","author":"MF Drummond","year":"2005"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.3109\/00016349.2010.512066","article-title":"Economic analysis of human papillomavirus triage, repeat cytology, and immediate colposcopy in management of women with minor cytological abnormalities in Sweden","volume":"89","author":"E Ostensson","year":"2010","journal-title":"Acta Obstet Gynecol Scand"},{"key":"ref33","article-title":"Cancer incidence in Sweden","year":"2010"},{"key":"ref34","article-title":"HPV vaccine in the Swedish vaccination prorgam","year":"2008"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/11591170-000000000-00000","article-title":"Economic and humanistic burden of external genital warts","volume":"30","author":"AJ Raymakers","year":"2012","journal-title":"Pharmacoeconomics"},{"key":"ref36","first-page":"69","article-title":"Recurrent external genital warts: a literature review","volume":"8","author":"WD Beutner KR","year":"1997","journal-title":"Papillomavirus Rep"},{"key":"ref37","unstructured":"United Kingdom National Guideline on the Management of Anogenital Warts, 2007. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.bashh.org\/documents\/86\/86.pdf\" xlink:type=\"simple\">www.bashh.org\/documents\/86\/86.pdf<\/ext-link>."},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/S0959-8049(98)00232-9","article-title":"Stage-specific treatment costs for cervical cancer in the United Kingdom","volume":"34","author":"JL Wolstenholme","year":"1998","journal-title":"Eur J Cancer"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1185\/030079906X99972","article-title":"Costs of detection and treatment of cervical cancer, cervical dysplasia and genital warts in the UK","volume":"22","author":"RE Brown","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"ref40","first-page":"1036","article-title":"Cervical cancer screening and associated treatment costs in France","volume":"34","author":"C Bergeron","year":"2006","journal-title":"Gynecol Obstet Fertil"},{"key":"ref41","first-page":"219","article-title":"Invasive cervical cancer treatment costs in France","volume":"94","author":"P Arveux","year":"2007","journal-title":"Bull Cancer"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"a1284","DOI":"10.1136\/bmj.a1284","article-title":"Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis","volume":"337","author":"M Arbyn","year":"2008","journal-title":"BMJ"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3201\/eid1301.060438","article-title":"Model for assessing human papillomavirus vaccination strategies","volume":"13","author":"EH Elbasha","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1017\/S0266462307080026","article-title":"Cost-effectiveness analysis of the introduction of a quadrivalent human papillomavirus vaccine in France","volume":"24","author":"C Bergeron","year":"2008","journal-title":"Int J Technol Assess Health Care"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1056\/NEJMoa061760","article-title":"Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases","volume":"356","author":"SM Garland","year":"2007","journal-title":"N Engl J Med"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/jama.290.6.781","article-title":"Potential health and economic impact of adding a human papillomavirus vaccine to screening programs","volume":"290","author":"SL Kulasingam","year":"2003","journal-title":"JAMA"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1071\/SH07043","article-title":"A cost-effectiveness analysis of adding a human papillomavirus vaccine to the Australian National Cervical Cancer Screening Program","volume":"4","author":"S Kulasingam","year":"2007","journal-title":"Sex Health"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"E406","DOI":"10.1016\/S2214-109X(14)70237-2","article-title":"Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study","volume":"2","author":"M Jit","year":"2014","journal-title":"Lancet Glob Health"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0139062","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T05:38:13Z","timestamp":1718084293000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0139062"}},"subtitle":[],"editor":[{"given":"Marcia Edilaine Lopes","family":"Consolaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,9,23]]},"references-count":48,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2015,9,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0139062","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,23]]}}}